Evaluation of secondary adrenal insufficiency

Findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel

Shih Yi Lin, Justin Ging Shing Won, Tin I. Lee, Kam Tsum Tang, Hong Da Lin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background. The corticotropin-releasing hormone (CRH) stimulation test is reliable for diagnosing pituitary or hypothalamic adrenal insufficiency. In the present study, we evaluated secondary adrenal insufficiency in patients with pituitary disease by CRH test and magnetic resonance imaging (MRI). Methods. A total of 12 healthy persons and 20 patients with pituitary disorder were recruited, including 6 with Sheehan's syndrome, 6 with idiopathic panhypopituitarism, 3 with isolated ACTH deficiency, 2 with pituitary apoplexy, 2 with empty sella syndrome and 1 with postoperative suprasellar tumor. Blood ACTH and cortisol levels were measured after 100 μg ovine CRH (oCRH) intravenous bolus infusion. Results. In patients, basal ACTH was 15.9 ± 17.3 pg/ml and basal cortisol was 4.8 ± 4.6 μg/dl. These values were significantly lower than those in controls (p = 0.02). In 11 of 20 patients (3 with Sheehan's syndrome, 3 with panhypopituitarism, 2 with empty sella, 2 with isolated ACTH deficiency and 1 with pituitary apoplexy), a delayed and prolonged ACTH response was observed. In the other 9 patients, ACTH showed little change. In all patients, there was no apparent increase in cortisol value. Moreover this value was significantly lower than in healthy persons (6.2 ± 5.4 vs. 21.1 ± 6.0 μg/dl; p < 0.0001). Sellar MRI showed complete empty change in all Sheehan's syndrome, apoplexy and empty sella syndrome patients. The six patients with panhypopituitarism had variable hypoplastic adenohypophysis with or without visible pituitary stalk. The three isolated ACTH deficiency cases demonstrated a normal anatomy. Conclusions. Our study showed that patients with pituitary disease had significantly lower plasma cortisol response after oCRH than controls. Thus, CRH testing appears useful for the diagnosis of central adrenal insufficiency. The two different functional ACTH responses to CRH observed in each pituitary disorder did not correlate with damage levels shown on MRI.

Original languageEnglish
Pages (from-to)156-163
Number of pages8
JournalChinese Medical Journal (Taipei)
Volume65
Issue number4
Publication statusPublished - 2002
Externally publishedYes

Fingerprint

Adrenal Insufficiency
Corticotropin-Releasing Hormone
Magnetic Resonance Imaging
Pituitary Diseases
Adrenocorticotropic Hormone
Hypopituitarism
Hydrocortisone
Empty Sella Syndrome
Pituitary Apoplexy
Sheep
Anterior Pituitary Gland
Pituitary Gland
Intravenous Infusions
Anatomy
Stroke

Keywords

  • Apoplexy
  • Corticotropin-releasing hormone
  • Empty sella
  • Idiopathic panhypopituitarism
  • Magnetic resonance imaging
  • Sheehan's syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evaluation of secondary adrenal insufficiency : Findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel. / Lin, Shih Yi; Won, Justin Ging Shing; Lee, Tin I.; Tang, Kam Tsum; Lin, Hong Da.

In: Chinese Medical Journal (Taipei), Vol. 65, No. 4, 2002, p. 156-163.

Research output: Contribution to journalArticle

@article{64ce35b07f3b474d8dbaf579c456e692,
title = "Evaluation of secondary adrenal insufficiency: Findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel",
abstract = "Background. The corticotropin-releasing hormone (CRH) stimulation test is reliable for diagnosing pituitary or hypothalamic adrenal insufficiency. In the present study, we evaluated secondary adrenal insufficiency in patients with pituitary disease by CRH test and magnetic resonance imaging (MRI). Methods. A total of 12 healthy persons and 20 patients with pituitary disorder were recruited, including 6 with Sheehan's syndrome, 6 with idiopathic panhypopituitarism, 3 with isolated ACTH deficiency, 2 with pituitary apoplexy, 2 with empty sella syndrome and 1 with postoperative suprasellar tumor. Blood ACTH and cortisol levels were measured after 100 μg ovine CRH (oCRH) intravenous bolus infusion. Results. In patients, basal ACTH was 15.9 ± 17.3 pg/ml and basal cortisol was 4.8 ± 4.6 μg/dl. These values were significantly lower than those in controls (p = 0.02). In 11 of 20 patients (3 with Sheehan's syndrome, 3 with panhypopituitarism, 2 with empty sella, 2 with isolated ACTH deficiency and 1 with pituitary apoplexy), a delayed and prolonged ACTH response was observed. In the other 9 patients, ACTH showed little change. In all patients, there was no apparent increase in cortisol value. Moreover this value was significantly lower than in healthy persons (6.2 ± 5.4 vs. 21.1 ± 6.0 μg/dl; p < 0.0001). Sellar MRI showed complete empty change in all Sheehan's syndrome, apoplexy and empty sella syndrome patients. The six patients with panhypopituitarism had variable hypoplastic adenohypophysis with or without visible pituitary stalk. The three isolated ACTH deficiency cases demonstrated a normal anatomy. Conclusions. Our study showed that patients with pituitary disease had significantly lower plasma cortisol response after oCRH than controls. Thus, CRH testing appears useful for the diagnosis of central adrenal insufficiency. The two different functional ACTH responses to CRH observed in each pituitary disorder did not correlate with damage levels shown on MRI.",
keywords = "Apoplexy, Corticotropin-releasing hormone, Empty sella, Idiopathic panhypopituitarism, Magnetic resonance imaging, Sheehan's syndrome",
author = "Lin, {Shih Yi} and Won, {Justin Ging Shing} and Lee, {Tin I.} and Tang, {Kam Tsum} and Lin, {Hong Da}",
year = "2002",
language = "English",
volume = "65",
pages = "156--163",
journal = "Journal of the Chinese Medical Association",
issn = "1726-4901",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - Evaluation of secondary adrenal insufficiency

T2 - Findings by corticotropin-releasing hormone test and magnetic resonance imaging in parallel

AU - Lin, Shih Yi

AU - Won, Justin Ging Shing

AU - Lee, Tin I.

AU - Tang, Kam Tsum

AU - Lin, Hong Da

PY - 2002

Y1 - 2002

N2 - Background. The corticotropin-releasing hormone (CRH) stimulation test is reliable for diagnosing pituitary or hypothalamic adrenal insufficiency. In the present study, we evaluated secondary adrenal insufficiency in patients with pituitary disease by CRH test and magnetic resonance imaging (MRI). Methods. A total of 12 healthy persons and 20 patients with pituitary disorder were recruited, including 6 with Sheehan's syndrome, 6 with idiopathic panhypopituitarism, 3 with isolated ACTH deficiency, 2 with pituitary apoplexy, 2 with empty sella syndrome and 1 with postoperative suprasellar tumor. Blood ACTH and cortisol levels were measured after 100 μg ovine CRH (oCRH) intravenous bolus infusion. Results. In patients, basal ACTH was 15.9 ± 17.3 pg/ml and basal cortisol was 4.8 ± 4.6 μg/dl. These values were significantly lower than those in controls (p = 0.02). In 11 of 20 patients (3 with Sheehan's syndrome, 3 with panhypopituitarism, 2 with empty sella, 2 with isolated ACTH deficiency and 1 with pituitary apoplexy), a delayed and prolonged ACTH response was observed. In the other 9 patients, ACTH showed little change. In all patients, there was no apparent increase in cortisol value. Moreover this value was significantly lower than in healthy persons (6.2 ± 5.4 vs. 21.1 ± 6.0 μg/dl; p < 0.0001). Sellar MRI showed complete empty change in all Sheehan's syndrome, apoplexy and empty sella syndrome patients. The six patients with panhypopituitarism had variable hypoplastic adenohypophysis with or without visible pituitary stalk. The three isolated ACTH deficiency cases demonstrated a normal anatomy. Conclusions. Our study showed that patients with pituitary disease had significantly lower plasma cortisol response after oCRH than controls. Thus, CRH testing appears useful for the diagnosis of central adrenal insufficiency. The two different functional ACTH responses to CRH observed in each pituitary disorder did not correlate with damage levels shown on MRI.

AB - Background. The corticotropin-releasing hormone (CRH) stimulation test is reliable for diagnosing pituitary or hypothalamic adrenal insufficiency. In the present study, we evaluated secondary adrenal insufficiency in patients with pituitary disease by CRH test and magnetic resonance imaging (MRI). Methods. A total of 12 healthy persons and 20 patients with pituitary disorder were recruited, including 6 with Sheehan's syndrome, 6 with idiopathic panhypopituitarism, 3 with isolated ACTH deficiency, 2 with pituitary apoplexy, 2 with empty sella syndrome and 1 with postoperative suprasellar tumor. Blood ACTH and cortisol levels were measured after 100 μg ovine CRH (oCRH) intravenous bolus infusion. Results. In patients, basal ACTH was 15.9 ± 17.3 pg/ml and basal cortisol was 4.8 ± 4.6 μg/dl. These values were significantly lower than those in controls (p = 0.02). In 11 of 20 patients (3 with Sheehan's syndrome, 3 with panhypopituitarism, 2 with empty sella, 2 with isolated ACTH deficiency and 1 with pituitary apoplexy), a delayed and prolonged ACTH response was observed. In the other 9 patients, ACTH showed little change. In all patients, there was no apparent increase in cortisol value. Moreover this value was significantly lower than in healthy persons (6.2 ± 5.4 vs. 21.1 ± 6.0 μg/dl; p < 0.0001). Sellar MRI showed complete empty change in all Sheehan's syndrome, apoplexy and empty sella syndrome patients. The six patients with panhypopituitarism had variable hypoplastic adenohypophysis with or without visible pituitary stalk. The three isolated ACTH deficiency cases demonstrated a normal anatomy. Conclusions. Our study showed that patients with pituitary disease had significantly lower plasma cortisol response after oCRH than controls. Thus, CRH testing appears useful for the diagnosis of central adrenal insufficiency. The two different functional ACTH responses to CRH observed in each pituitary disorder did not correlate with damage levels shown on MRI.

KW - Apoplexy

KW - Corticotropin-releasing hormone

KW - Empty sella

KW - Idiopathic panhypopituitarism

KW - Magnetic resonance imaging

KW - Sheehan's syndrome

UR - http://www.scopus.com/inward/record.url?scp=0036308579&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036308579&partnerID=8YFLogxK

M3 - Article

VL - 65

SP - 156

EP - 163

JO - Journal of the Chinese Medical Association

JF - Journal of the Chinese Medical Association

SN - 1726-4901

IS - 4

ER -